Skip to main content

Table 3 Univariate and multivariate analyses predicting LNM using postoperative values

From: Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study

Variable

Univariate

Multivariate

OR (95 % CI)

p-value

OR (95 % CI)

p-value

Gender

Male

1

0.118

  
 

Female

1.46 (0.91–2.34)

   

Agea

 

0.98 (0.96–0.99)

0.025

0.97 (0.94–0.99)

0.002

BMIa

 

1.00 (0.93–1.08)

0.977

  

Gross type

0-I, IIa

1

<0.001

  
 

IIb

0.51 (0.13–2.28)

   
 

IIc, III

0.92 (0.28–3.09)

   
 

AGC

8.33 (2.37–29.29)

   

Histology

Pap, WD, MD

1

0.001

  
 

Muc, PD

2.65 (1.51–4.64)

0.001

  
 

Sig

0.86 (0.45–1.66)

0.654

  
 

CLS

0.0 (0.00–0.00)

0.999

  

Ulcer

Negative

1

0.113

  
 

Positive

1.52 (0.91–2.54)

   

Location

Upper third

1

0.145

  
 

Lower or middle third

0.63 (0.33–1.18)

   

Tumor sizea

 

1.03 (1.02–1.05)

<0.001

1.02 (1.01–1.04)

<0.001

T-stage

Mucosa

1

<0.001

1

<0.001

 

Submucosa

5.13 (2.63–9.99)

<0.001

5.44 (2.76–10.71)

<0.001

 

Proper muscle

11.73 (4.90–28.08)

<0.001

10.23 (4.21–24.84)

<0.001

 

Subserosa

192.0 (36.82–1001.32)

<0.001

149.40 (27.21–820.33)

<0.001

 

Serosa invasion

42.0 (13.11–134.56)

<0.001

28.62 (8.32–98.42)

<0.001

  1. aAnalyses were performed using continuous values
  2. LNM lymph node metastasis, OR odds ratio, CI confidence interval, BMI body-mass index, Pap papillary adenocarcinoma, WD well differentiated adenocarcinoma, MD moderately differentiated adenocarcinoma, Muc mucinous adenocarcinoma, PD poorly differentiated adenocarcinoma, Sig signet cell ring carcinoma, CLS carcinoma with lymphoid stroma